Search Results

Ergomed plc and Permira Advisers LLP, are pleased to announce the completion of the acquisition of Ergomed by funds advised by Permira for £703.1 million.

Medidata , a Dassault Systèmes company, announced that Ergomed’s Rare Disease Innovation Center TM will leverage Medidata’s Patient Cloud, Intelligent Trials technologies, and Synthetic Control Arm Ⓡ to help sponsors reduce clinical trial timelines, optimize patient experiences, and bring effective rare disease therapies to market more quickly.

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, announces a trading update for the year ended 31 December 2019.

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, announced the appointment of Lewis Cameron as Chief Operating Officer (COO) and to the Board.

Ergomed plc (LSE: ERGO) (‘Ergomed’ or ‘the Company’), a company focused on providing specialised services to the pharmaceutical industry, today provides a trading update for the year ended 31 December 2018.

Ergomed plc will announce its interim results for the six months ending 30 June 2019 on 25September 2019.

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, announces Board and management changes.